Ngā hua rapu - Fraser Symmans
- E whakaatu ana i te 1 - 20 hua o te 140
- Haere ki te Whārangi Whai Ake
-
1
-
2
Fine-needle aspiration cytology of Hodgkin disease mā David C. Chhieng, Joan Cangiarella, W. Fraser Symmans, Jean‐Marc Cohen
I whakaputaina 2001Artigo -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Clinical, Histopathologic, and Immunohistochemical Features of Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma mā Ibrahim Khalifeh, Constance T. Albarracin, Leslie K. Diaz, Fraser Symmans, Mary E. Edgerton, Rosa F. Hwang, Nour Sneige
I whakaputaina 2008Artigo -
12
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy mā Florentia Peintinger, Bruno V. Sinn, Christos Hatzis, Constance T. Albarracin, Erinn Downs‐Kelly, Jerzy Morkowski, Rebekah Gould, W. Fraser Symmans
I whakaputaina 2015Artigo -
13
Evaluation of biological pathways involved in chemotherapy response in breast cancer mā Attila Tordai, Jing Wang, Fabrice André, Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai
I whakaputaina 2008Artigo -
14
Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers mā Christos Hatzis, Hongxia Sun, Hui Yao, R Hubbard, Funda Meric‐Bernstam, Gildy V. Babiera, Yun Wu, Lajos Pusztai, W. Fraser Symmans
I whakaputaina 2011Artigo -
15
-
16
Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer mā Jae K. Lee, Charles Coutant, Young Chul Kim, Yuan Qi, Dan Theodorescu, W. Fraser Symmans, Keith Baggerly, Roman Rouzier, Lajos Pusztai
I whakaputaina 2010Artigo -
17
Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer mā Fabrice André, Christos Hatzis, K. Anderson, Christos Sotiriou, Chafika Mazouni, Jaime Mejia, Bailiang Wang, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai
I whakaputaina 2007Artigo -
18
Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2 <sup>+</sup> :ERα <sup>−</sup> breast cancer mā Jeff C. Liu, Véronique Voisin, Gary D. Bader, Tao Deng, Lajos Pusztai, W. Fraser Symmans, Francisco J. Esteva, Sean E. Egan, Eldad Zacksenhaus
I whakaputaina 2012Artigo -
19
The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues mā Michał Marczyk, Chunxiao Fu, Rosanna Lau, Lili Du, Alexander J. Trevarton, Bruno V. Sinn, Rebekah Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans
I whakaputaina 2019Artigo -
20
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy mā Judy C. Boughey, Karla V. Ballman, Linda McCall, Elizabeth A. Mittendorf, W. Fraser Symmans, Thomas B. Julian, David R. Byrd, Kelly K. Hunt
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Medicine
Breast cancer
Internal medicine
Oncology
Biology
Chemotherapy
Cancer research
Gene
Genetics
Pathology
Biochemistry
Estrogen receptor
Neoadjuvant therapy
Triple-negative breast cancer
Gene expression
Bioinformatics
Immunohistochemistry
Biomarker
Clinical trial
Confidence interval
Metastasis
Paclitaxel
Taxane
Computer science
Hazard ratio
Paleontology
Trastuzumab
Immunotherapy
Progesterone receptor